The opening session of BBDF day two brought project completion into focus, with discussion centering on the very real work required to get a ready-to-build project across the line. Industry experts ...

BBDF is spearheading a unique, cohesive strategy, incorporating independent scientific resources and collaboration with related organizations to drive research in juvenile Batten Disease. Today there ...

Presentation of preclinical data demonstrating how Batten-1 drastically reduces the buildup of toxic glycosphingolipids in Batten disease and a poster describing for the first time the burden of ...

The New York Stem Cell Foundation (NYSCF) and Beyond Batten Disease Foundation (BBDF) today announce the availability of a unique and comprehensive collection of juvenile Batten (CLN3) disease induced ...

Europe’s battery storage has matured, but remains dynamic with strong growth across markets. That was one of the key takeaways from the opening session of the Battery Business Development Forum (BBDF) ...

Lyon, 21 October 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases, and the Beyond Batten Disease Foundation (BBDF) today announced the European ...

" With the FDA's IND approval for BBDF 101, we have reached a significant milestone in the drug's regulatory development plan. This approval will enable us to start clinical development of BBDF 101 in ...

AUSTIN, Texas, March 2, 2021 /PRNewswire/ -- Beyond Batten Disease Foundation (BBDF) is pleased to announce an agreement with Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson ...

The three partners are proud to jointly serve as Platinum Sponsors of the 2026 BDSRA Annual Family Conference, where they will provide an update on the Batten-1 program and the upcoming initiation of ...

THERANEXUS - THX Pharma, Biocodex and the Beyond Batten Disease Foundation Stand Together with the CLN3 Batten Community on International Batten Disease Awareness Day ...